Meta description: A regulatory update on a device trial of capacitive and resistive electrical transfer therapy for hamstring injuries published on February 20 2026.
On February 20 2026 regulatory watchers are reviewing a ClinicalTrials.gov entry for a device trial addressing hamstring injuries. The study lists a capacitive and resistive electrical transfer therapy device called T Plus from Wintecare SA in Chiasso Switzerland. The sponsor is Hacettepe University and recruitment is currently ongoing. The record points to coordination with exercise as part of the intervention. There is no published efficacy result yet.
What changed in the hamstring injury trial?
Study details and device use
The ClinicalTrials.gov entry NCT07421570 lists interventions that include a device labeled T Plus from Wintecare SA in Chiasso. The trial also lists exercise as another intervention. The sponsor is Hacettepe University. Recruitment status shows the study is currently recruiting. The description indicates the focus on a hamstring injury condition.
How is the device used and what is the study design?
Treatment protocol and device description
The device named T Plus is described in the record as part of capacitive and resistive electrical transfer therapy. The intervention is combined with exercise as part of a treatment plan for hamstring injuries. The entry demonstrates a collaboration between Wintecare SA in Switzerland and a sponsoring university located in Turkey. See the official trial page on ClinicalTrials.gov for full details.
For official trial information see the ClinicalTrials.gov record at ClinicalTrials.gov record NCT07421570.
What regulatory considerations apply to the trial?
Safety and regulatory context
The trial activity aligns with the standard regulatory framework for investigational devices. The description identifies a device called T Plus and notes the involvement of an academic sponsor. The record indicates the trial is conducted under the oversight applicable to clinical investigations of medical devices in collaboration with the sponsor and manufacturer statements where present. Any final labeling will reflect the intended use and performance claims as supported by regulatory submissions.
Readers should consult the trial page and related regulatory guidance for jurisdiction specific requirements. See also the sponsor statements where provided.
What evidence and safety considerations exist?
Evidence status and risk management
As of the posting date there are no trial results published in the record. The absence of published efficacy data means clinicians should await peer reviewed results before applying the device in routine care. Safety considerations follow the standard risks associated with electrical stimulation devices and will be addressed in the trial protocol and risk management plan. The information presented here reflects what is stated in the source record.
FAQ
- What device is studied and what interventions are involved The study uses a device called T Plus from Wintecare SA and lists exercise as another intervention.
- Who sponsors and where is the trial conducted The sponsor is Hacettepe University and the listing references Switzerland and Turkey as locations.
- Where can I find official trial information The official record is on ClinicalTrials.gov and can be accessed via the link in this article or by visiting the ClinicalTrials.gov page.
Conclusion and implications for professionals
In summary the record shows an investigational capacitive and resistive electrical transfer therapy device used with exercise to treat hamstring injuries. The sponsor is an academic institution Hacettepe University and recruitment is ongoing. Regulators and clinicians should monitor status changes and ensure alignment with international and local risk management and labeling requirements. Decisions on clinical use await trial outcomes and regulatory clearance.
Disclaimer
This article is intended for professionals. It is not legal advice. Readers should seek appropriate regulatory counsel before relying on the information here.
Announcement line
For full information about the announcement, see the link below.
On the next line place the link as a full URL. Add an anchor ID.
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07421570?term=medical+device
External link to ClinicalTrials.gov is provided for reference only.
Internal references: Regulatory affairs related updates and Medical devices news.